Immunocore Holdings plc (FRA:6YG)
27.40
-1.00 (-3.52%)
Last updated: Oct 23, 2026, 9:55 PM CEST
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of €1.42 billion as of October 23, 2026. Its market cap has increased by 0.99% in one year.
Market Cap
1.42B
Enterprise Value
1.03B
Revenue
377.06M
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has decreased from 1.49B to 1.42B, a decrease of -4.57%. That is a compound annual growth rate of -0.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 1.42B | -4.63% |
| Dec 31, 2025 | 1.49B | 4.78% |
| Dec 31, 2024 | 1.43B | -53.35% |
| Dec 29, 2023 | 3.06B | 19.45% |
| Dec 30, 2022 | 2.56B | 93.80% |
| Dec 31, 2021 | 1.32B | -11.59% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 62.30B |
| Siemens Healthineers AG | 46.59B |
| Bayer Aktiengesellschaft | 43.21B |
| Fresenius SE & Co. KGaA | 25.97B |
| Carl Zeiss Meditec AG | 3.11B |
| Dermapharm Holding SE | 1.90B |
| Drägerwerk AG & Co. KGaA | 1.61B |
| Redcare Pharmacy NV | 1.60B |